Dock3 interaction with a glutamate-receptor NR2D subunit protects neurons from excitotoxicity

Molecular Brain

Volumn 6, Issue 1, 2013, Pages

  Bai, Ning ^a,c   Hayashi, Hideki ^d   Aida, Tomomi ^a   Namekata, Kazuhiko ^e   Harada, Takayuki ^e   Mishina, Masayoshi ^f   Tanaka, Kohichi ^a,b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c CHINA MEDICAL UNIVERSITY   (China)

^d KUMAMOTO UNIVERSITY   (Japan)

^e TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^f RITSUMEIKAN UNIVERSITY   (Japan)

Author keywords

Dock3; Excitotoxicity; Glaucoma; Glutamate transporter; Memantine; NMDA receptor; NR2D

Indexed keywords

BINDING PROTEIN; DEDICATOR OF CYTOKINESIS 3; EXCITATORY AMINO ACID TRANSPORTER; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2D; UNCLASSIFIED DRUG; CALCIUM; CARRIER PROTEIN; DOCK3 PROTEIN, MOUSE; EXCITATORY AMINO ACID TRANSPORTER 1; GLUTAMIC ACID DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYLASPARTIC ACID; NERVE PROTEIN; NEUROTOXIN; NR2D NMDA RECEPTOR; PROTEIN BINDING; PROTEIN SUBUNIT; SLC1A3 PROTEIN, MOUSE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL DEATH; CONTROLLED STUDY; EXCITOTOXICITY; LOW TENSION GLAUCOMA; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RETINA GANGLION CELL; ANIMAL; BRAIN; CELL MEMBRANE; CELL PROTECTION; DEFICIENCY; DRUG EFFECTS; HEK293 CELL LINE; HUMAN; INTRACELLULAR SPACE; METABOLISM; NERVE CELL; PATHOLOGY; PROTEIN SUBUNIT; PROTEIN TRANSPORT; RETINA; TOXICITY;

MUS;

ANIMALS; BRAIN; CALCIUM; CARRIER PROTEINS; CELL DEATH; CELL MEMBRANE; CYTOPROTECTION; EXCITATORY AMINO ACID TRANSPORTER 1; GLUTAMATES; HEK293 CELLS; HUMANS; INTRACELLULAR SPACE; MICE; N-METHYLASPARTATE; NERVE TISSUE PROTEINS; NEURONS; NEUROTOXINS; PROTEIN BINDING; PROTEIN SUBUNITS; PROTEIN TRANSPORT; RECEPTORS, N-METHYL-D-ASPARTATE; RETINA; RETINAL GANGLION CELLS;

EID: 84877002440     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/1756-6606-6-22     Document Type: Article

References (47)

1. Glutamate receptors: brain function and signal transduction. Nakanishi S, Nakajima Y, Masu M, Ueda Y, Nakahara K, Watanabe D, Yamaguchi S, Kawabata S, Okada M, Brain Res Brain Res Rev 1998 26 230 235 10.1016/S0165-0173(97)00033-7 9651535
2. Glutamate neurotoxicity and diseases of the nervous system. Choi DW, Neuron 1988 1 623 634 10.1016/0896-6273(88)90162-6 2908446
3. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Choi DW, Rothman SM, Annu Rev Neurosci 1990 13 171 182 10.1146/annurev.ne.13. 030190.001131 1970230
4. The glutamate receptor ion channels. Dingledine R, Borges K, Bowie D, Traynelis SF, Pharmacol Rev 1999 51 7 61 10049997
5. Glutamate and epilepsy. Chapman AG, J Nutr 2000 130 4S Suppl 1043S 1045S 10736378
6. Glutamatergic animal models of schizophrenia. Moghaddam B, Jackson ME, Ann N Y Acad Sci 2003 1003 131 137 10.1196/annals.1300.065 14684441
7. Amino acids as dietary excitotoxins: a contribution to understanding neurodegenerative disorders. Meldrum B, Brain Res Brain Res Rev 1993 18 293 314 10.1016/0165-0173(93)90014-Q 8401596
8. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH, Neuron 1994 12 529 540 10.1016/0896-6273(94)90210-0 7512349
9. Role of distinct NMDA receptor subtypes at central synapses. Cull-Candy SG, Leszkiewicz DN, Sci STKE 2004 2004 e16 15494561
10. Developmental changes in distribution of NMDA receptor channel subunit mRNAs. Watanabe M, Inoue Y, Sakimura K, Mishina M, Neuroreport 1992 3 1138 1140 10.1097/00001756-199212000-00027 1493227
11. Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine. Kotermanski SE, Johnson JW, J Neurosci 2009 29 2774 2779 10.1523/JNEUROSCI.3703-08.2009 19261873
12. Essential role of NMDA receptor channel 4 subunit (GluN2D) in the effects of phencyclidine, but not methamphetamine. Hagino Y, Kasai S, Han W, Yamamoto H, Nabeshima T, Mishina M, Ikeda K, PLoS One 2010 5 13722 10.1371/journal.pone. 0013722 21060893
13. Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. Ishii T, Moriyoshi K, Sugihara H, Sakurada K, Kadotani H, Yokoi M, Akazawa C, Shigemoto R, Mizuno N, Masu M, J Biol Chem 1993 268 2836 2843 8428958
14. Distinct NMDA receptor subpopulations contribute to long-term potentiation and long-term depression induction. Hrabetova S, Serrano P, Blace N, Tse HW, Skifter DA, Jane DE, Monaghan DT, Sacktor TC, J Neurosci 2000 20 C81 10827202
15. Expression of mRNA for glutamate receptor subunits distinguishes the major classes of retinal neurons, but is less specific for individual cell types. Jakobs TC, Ben Y, Masland RH, Mol Vis 2007 13 933 948 17653033
16. The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. Harada T, Harada C, Nakamura K, Quah HM, Okumura A, Namekata K, Saeki T, Aihara M, Yoshida H, Mitani A, J Clin Invest 2007 117 1763 1770 10.1172/JCI30178 17607354
17. Postsynaptic density protein-95 regulates NMDA channel gating and surface expression. Lin Y, Skeberdis VA, Francesconi A, Bennett MV, Zukin RS, J Neurosci 2004 24 10138 10148 10.1523/JNEUROSCI.3159-04.2004 15537884
18. NMDA receptor trafficking through an interaction between PDZ proteins and the exocyst complex. Sans N, Prybylowski K, Petralia RS, Chang K, Wang YX, Racca C, Vicini S, Wenthold RJ, Nat Cell Biol 2003 5 520 530 10.1038/ncb990 12738960
19. Growth factor-dependent trafficking of cerebellar NMDA receptors via protein kinase B/Akt phosphorylation of NR2C. Chen BS, Roche KW, Neuron 2009 62 471 478 10.1016/j.neuron.2009.04.015 19477150
20. NMDA channel regulation by channel-associated protein tyrosine kinase Src. Yu XM, Askalan R, Keil GJ, Salter MW, Science 1997 275 674 678 10.1126/science.275.5300.674 9005855
21. Isolation and characterization of novel presenilin binding protein. Kashiwa A, Yoshida H, Lee S, Paladino T, Liu Y, Chen Q, Dargusch R, Schubert D, Kimura H, J Neurochem 2000 75 109 116 10854253
22. A potential neuroprotective role of apolipoprotein E-containing lipoproteins through low density lipoprotein receptor-related protein 1 in normal tension glaucoma. Hayashi H, Eguchi Y, Fukuchi-Nakaishi Y, Takeya M, Nakagata N, Tanaka K, Vance JE, Tanihara H, J Biol Chem 2012 287 25395 25406 10.1074/jbc.M112.370130 22674573
23. Molecular basis of glutamate toxicity in retinal ganglion cells. Sucher NJ, Lipton SA, Dreyer EB, Vision Res 1997 37 3483 3493 10.1016/S0042-6989(97) 00047-3 9425525
24. Internalization of ionotropic glutamate receptors in response to mGluR activation. Snyder EM, Philpot BD, Huber KM, Dong X, Fallon JR, Bear MF, Nat Neurosci 2001 4 11 1079 1085 10.1038/nn746 11687813
25. Molecular determinants of NMDA receptor internalization. Roche KW, Standley S, McCallum J, Dune Ly C, Ehlers MD, Wenthold RJ, Nat Neurosci 2001 4 794 802 10.1038/90498 11477425
26. Glycine binding primes NMDA receptor internalization. Nong Y, Huang YQ, Ju W, Kalia LV, Ahmadian G, Wang YT, Salter MW, Nature 2003 422 302 307 10.1038/nature01497 12646920
27. High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease. Tamura H, Kawakami H, Kanamoto T, Kato T, Yokoyama T, Sasaki K, Izumi Y, Matsumoto M, Mishima HK, J Neurol Sci 2006 246 79 83 10.1016/j.jns.2006.02.009 16564058
28. Identification of single-nucleotide polymorphisms in the human N-methyl-D-aspartate receptor subunit NR2D gene, GRIN2D, and association study with schizophrenia. Makino C, Shibata H, Ninomiya H, Tashiro N, Fukumaki Y, Psychiatr Genet 2005 15 215 221 10.1097/00041444-200509000-00014 16094258
29. Interaction of the N-methyl-D-aspartate receptor complex with a novel synapse-associated protein, SAP102. Lau LF, Mammen A, Ehlers MD, Kindler S, Chung WJ, Garner CC, Huganir RL, J Biol Chem 1996 271 21622 21628 10.1074/jbc.271.35.21622 8702950
30. Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Kornau HC, Schenker LT, Kennedy MB, Seeburg PH, Science 1995 269 1737 1740 10.1126/science.7569905 7569905
31. Interaction of the N-methyl-D-aspartic acid receptor NR2D subunit with the c-Abl tyrosine kinase. Glover RT, Angiolieri M, Kelly S, Monaghan DT, Wang JY, Smithgall TE, Buller AL, J Biol Chem 2000 275 12725 12729 10.1074/jbc.275.17.12725 10777567
32. Modifier of cell adhesion regulates N-cadherin-mediated cell-cell adhesion and neurite outgrowth. Chen Q, Chen TJ, Letourneau PC, Costa La F, Schubert D, J Neurosci 2005 25 281 290 10.1523/JNEUROSCI.3692-04.2005 15647471
33. Presenilin binding protein is associated with neurofibrillary alterations in Alzheimer's disease and stimulates tau phosphorylation. Chen Q, Yoshida H, Schubert D, Maher P, Mallory M, Masliah E, Am J Pathol 2001 159 1597 1602 10.1016/S0002-9440(10)63005-2 11696419
34. A novel mechanism for the regulation of amyloid precursor protein metabolism. Chen Q, Kimura H, Schubert D, J Cell Biol 2002 158 79 89 10.1083/jcb.200110151 12093789
35. Loss of modifier of cell adhesion reveals a pathway leading to axonal degeneration. Chen Q, Peto CA, Shelton GD, Mizisin A, Sawchenko PE, Schubert D, J Neurosci 2009 29 118 130 10.1523/JNEUROSCI.3985-08.2009 19129390
36. Dock3 stimulates axonal outgrowth via GSK-3β-mediated microtubule assembly. Namekata K, Harada C, Guo X, Kimura A, Kittaka D, Watanabe H, Harada T, J Neurosci 2012 32 264 274 10.1523/JNEUROSCI.4884-11.2012 22219288
37. Regulation of Kir2.1 channels by the Rho-GTPase, Rac1. Boyer SB, Slesinger PA, Jones SV, J Cell Physiol 2009 218 385 393 10.1002/jcp.21610 18932198
38. Developmental regulation of tyrosine phosphorylation of the NR2D NMDA glutamate receptor subunit in rat central nervous system. Dunah AW, Yasuda RP, Wolfe BB, J Neurochem 1998 71 1926 1934 9798917
39. Reduced spontaneous activity of mice defective in the epsilon 4 subunit of the NMDA receptor channel. Ikeda K, Araki K, Takayama C, Inoue Y, Yagi T, Aizawa S, Mishina M, Brain Res Mol Brain Res 1995 33 61 71 10.1016/0169-328X(95) 00107-4 8774946
40. Motor discoordination and increased susceptibility to cerebellar injury in GLAST mutant mice. Watase K, Hashimoto K, Kano M, Yamada K, Watanabe M, Inoue Y, Okuyama S, Sakagawa T, Ogawa S, Kawashima N, Eur J Neurosci 1998 10 976 988 10.1046/j.1460-9568.1998.00108.x 9753165
41. Overexpression of optineurin E50K disrupts Rab8 interaction and leads to a progressive retinal degeneration in mice. Chi ZL, Akahori M, Obazawa M, Minami M, Noda T, Nakaya N, Tomarev S, Kawase K, Yamamoto T, Noda S, Hum Mol Genet 2010 19 2606 2615 10.1093/hmg/ddq146 20388642
42. Involvement of the carboxyl-terminal region in modulation by TPA of the NMDA receptor channel. Mori H, Yamakura T, Masaki H, Mishina M, Neuroreport 1993 4 519 522 10.1097/00001756-199305000-00014 7685642
43. Cloning and expression of the epsilon 4 subunit of the NMDA receptor channel. Ikeda K, Nagasawa M, Mori H, Araki K, Sakimura K, Watanabe M, Inoue Y, Mishina M, FEBS Lett 1992 313 34 38 10.1016/0014-5793(92)81178-O 1385220
44. Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. Khosravani H, Zhang Y, Tsutsui S, Hameed S, Altier C, Hamid J, Chen L, Villemaire M, Ali Z, Jirik FR, J Cell Biol 2008 181 551 565 10.1083/jcb. 200711002 18443219
45. Target-cell-specific left-right asymmetry of NMDA receptor content in schaffer collateral synapses in epsilon1/NR2A knock-out mice. Wu Y, Kawakami R, Shinohara Y, Fukaya M, Sakimura K, Mishina M, Watanabe M, Ito I, Shigemoto R, J Neurosci 2005 25 9213 9226 10.1523/JNEUROSCI.2134-05.2005 16207881
46. Dock3 induces axonal outgrowth by stimulating membrane recruitment of the WAVE complex. Namekata K, Harada C, Taya C, Guo X, Kimura H, Parada LF, Harada T, Proc Natl Acad Sci U S A 2010 107 7586 7591 10.1073/pnas.0914514107 20368433
47. The lipid sulfatide is a novel myelin-associated inhibitor of CNS axon outgrowth. Winzeler AM, Mandemakers WJ, Sun MZ, Stafford M, Phillips CT, Barres BA, J Neurosci 2011 31 6481 6492 10.1523/JNEUROSCI.3004-10.2011 21525289